Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trimetrexate with Leucovorin for PCP in AIDS Patients Intolerant to Standard Therapy
NCT00001016Phase 3Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of trimetrexate glucuronate in Pneumocystis jirovecii pneumonia (PJP), sponsored by National Institute of Allergy and Infectious Diseases. Status: completed.
02
Drugs
trimetrexate glucuronate
03
Conditions
Pneumocystis jirovecii pneumonia (PJP)
Beyond the preview
Go deeper on NCT00001016.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00001016.